GEHC Stock: Price, Earnings History and SEC Filings
GE HealthCare Technologies Inc. (GEHC) last traded at $76.57, up 0.20% on the latest session and up 17.1% over the past month. In its most recent reported quarter (Sep 2026) earnings per share were $1.34 against an analyst estimate of $1.21, a beat of 10.7%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
GEHC earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 2026 | Oct 28, 2026 | $1.34 | $1.21 | +10.74% |
| Jun 2026 | Jul 29, 2026 | $1.13 | $1.04 | +8.65% |
| Mar 2026 | Apr 29, 2026 | $0.99 | $1.07 | -7.48% |
| Dec 2025 | Feb 4, 2026 | $1.44 | $1.43 | +0.70% |
GEHC beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.
How GEHC reacts to earnings
Across its last 8 earnings releases, GEHC moved 6.6% on average the next session, in either direction. It rose after 4 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-10-28 | Before open | +6.62% |
| 2026-07-29 | Before open | +12.15% |
| 2026-07-23 | After close | -2.27% |
| 2026-04-29 | Before open | -13.16% |
| 2026-02-04 | Before open | +4.89% |
| 2025-10-29 | Before open | -2.54% |
| 2025-07-30 | Before open | -7.82% |
| 2025-04-30 | Before open | +3.29% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
GEHC financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $20.6B | $2.1B | – | 10.1% | $4.55 |
| 2024 | $19.7B | $2.0B | – | 10.1% | $4.34 |
| 2023 | $19.6B | $1.6B | – | 8.0% | $3.03 |
| 2022 | $18.3B | $1.9B | – | 10.4% | $4.22 |
| 2021 | $17.6B | $2.2B | – | 12.8% | $4.95 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for GEHC
- 10-Q · Oct 28, 2026
- 8-K · Oct 28, 2026Results of operations, Officer or director change, Financial statements and exhibits
- 8-K · Sep 22, 2026Officer or director change, Regulation FD disclosure, Financial statements and exhibits
- 8-K · Aug 18, 2026Officer or director change, Financial statements and exhibits
- 8-K · Jul 29, 2026Regulation FD disclosure, Financial statements and exhibits
- 10-Q · Jul 29, 2026
- 8-K · Jul 29, 2026Results of operations, Financial statements and exhibits
- 8-K · Jul 23, 2026Results of operations, Officer or director change, Financial statements and exhibits
- 8-K · May 11, 2026Shareholder vote, Other events
- 10-Q · Apr 29, 2026
Insider filing activity
GEHC insiders filed 16 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
GEHC news
- GE HealthCare debuts Allia Celeo, a ceiling-mounted interventional system designed for smooth procedural flow and AI-powered precision imagingNov 1, 2026 · finance.yahoo.com
- ISRG Sales Jump 22%: Can Growth Stay Ahead of Procedure Volumes?Oct 29, 2026 · finance.yahoo.com
- GEHC vs. HAE: Which Stock Is the Better Value Option?Oct 29, 2026 · finance.yahoo.com
- What Sent GE HealthCare Stock Higher?Oct 29, 2026 · trefis.com
- GE HealthCare raises 2026 outlook after positive Q3Oct 29, 2026 · medicaldevice-network.com
- GE Vernova Places High-Voltage, $9 Billion Bet on Energy EquipmentOct 29, 2026 · thedailyupside.com
- GE HealthCare Technologies Q3 Earnings Call HighlightsOct 29, 2026 · marketbeat.com
- GE HealthCare (GEHC) stock trades up, here is whyOct 29, 2026 · finance.yahoo.com
About GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. (GEHC) is a US-listed public company on Nasdaq. The SEC classifies its business as X-ray Apparatus & Tubes & Related Irradiation Apparatus. It is incorporated in DE. Its fiscal year ends in December.